Seer Announces $55 Million in Series D Equity Financing Bringing in New Investors aMoon Fund and T. Rowe Price Funds

Capital will enable continued advancement of novel Proteograph™ platform and commercialization of first-in-class proteomics products Seer, Inc., a life sciences company focused on capturing and translating proteome insights to advance human health, today announced it has raised $55 million in an oversubscribed Series D equity financing. The round was led by healthtech and life sciences [...]

BIO-TECHNE’S EXOSOME DIAGNOSTICS LAB RECEIVES ACCREDITATION FROM COLLEGE OF AMERICAN PATHOLOGISTS (CAP)

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ:TECH) today announced that the Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to its Exosome Diagnostics (ExosomeDx) laboratory based on results of a recent on-site inspection as part of the CAP's Accreditation Program. ExosomeDx was advised of this national recognition and congratulated for the excellence of [...]

Abcam and SomaServe Announce Comprehensive Partnership to Realise the Potential of PolyNaut® ‘Bionic’ Nanoparticles for Delivery to Live Cells

Commercialise novel cell delivery platform technology Develop novel delivery methods for research applications Revolutionise utility of live cell imaging to explore disease CAMBRIDGE, UK -- Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut® Technology, have announced a partnership to commercialise the cell delivery [...]

Micromeritics Names Industry Expert, Carrie Mautz, Marketing Manager, North America

Newly Created Position Underscores Company’s Commitment to Supporting Sales and Marketing Efforts in the Region   Norcross, GA – Micromeritics Instrument Corporation, a global leader in material characterization technology, today announced it has named Carrie Mautz to the newly created position of Marketing Manager, North America.   Carrie had spent 15 years with industry giant Thermo Fisher [...]

Enhanced production technology enables InSphero to reduce pricing of 3D InSight™ Human Liver Microtissues for broader access to assay-ready spheroid technology

New pricing structure will enable researchers to save close to 50% on 3D models for liver toxicology and drug safety testing applications. PDF Version Schlieren, Switzerland – InSphero AG, the market leader in 3D cell-based assay technology, today announced that upgrades to its unparalleled production technology has enabled the company to reduce the price of its popular [...]

GE Healthcare Life Sciences and UMass Medical School Establish Large Scale Viral Vector Manufacturing Facility

New facility will help alleviate bottlenecks in manufacturing that impact preclinical research December 16, 2019 - GE Healthcare (GEHC) Life Sciences and the University of Massachusetts Medical School (UMMS) have come together to establish a Large Scale Viral Vector Manufacturing Facility. The new facility will provide large quantities of high-quality recombinant adeno-associated virus (AAV) vectors for preclinical research. [...]

Ampersand Capital Partners Acquires Peptides International And Merges Company With New England Peptide

WELLESLEY, Mass., GARDNER, Mass. and LOUISVILLE, Ky. -- Ampersand Capital Partners announced today that it has completed the acquisition of Peptides International and merged it with existing portfolio company New England Peptide. This merger brings together two leading providers of peptide synthesis services as well as a broad catalog of unique peptide products to assist in [...]

Nikon Announces Artificial Intelligence (AI) for Predictive Imaging, Image segmentation and Processing

NIS.ai enables researchers to easily and accurately extract unbiased data from vast amounts of datasets Nikon Instruments Inc., innovator of advanced microscope systems, today announced NIS.ai, a powerful image analysis and processing module for NIS-Elements that leverages Deep Learning and Artificial Intelligence. NIS.ai is a suite of new AI-based processing tools that utilizes convolutional neural networks to learn [...]

Bio-Rad Makes Progress Recovering from Recent Ransomware Attack

HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) a global leader of life science research and clinical diagnostic products, today announced that the Company is making good progress recovering from a ransomware attack that was detected on Bio-Rad’s network on December 5, 2019. Once the malicious software was detected, Bio-Rad immediately took certain systems offline [...]

Call for Entries: Eppendorf Award 2020

Hamburg, December 2019   Until January 15, 2020, researchers up to 35 years, with an advanced degree, who are working in Europe are invited to apply online for the Eppendorf Award for Young European Investigators 2020. This prize acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical [...]

Access IBO on Knowledge Center